JD Health prices HK$27bn IPO high on strong investor support

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

JD Health prices HK$27bn IPO high on strong investor support

Jonathan Breen
December 02, 2020 06:00 am
Pharma_drugs_adobe_575x375.jpg
siro46 - stock.adobe.com

JD Health International has raised HK$27bn ($3.5bn) after sealing its IPO at the top end of the marketed range, following a flood of global investor demand.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • ✔ 4,000 annual insights
  • ✔ 700+ notes and long-form analyses
  • ✔ 4 capital markets databases
  • ✔ Daily newsletters across markets and asset classes
  • ✔ 2 weekly podcasts

Topics

CITIC SecuritiesEquity IPOsHealth and BiotechUBSEquityChina Merchants Bank CoChinaJefferies LLCHong Kong SARICBCAsiaGreater ChinaBank of CommunicationsHaitong SecuritiesNortheast AsiaGuotai Junan Securities CoAsia PacificSRIDBSBank of AmericaMizuhoEmerging MarketsGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article